Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
This study has been completed.
Study NCT00181987 Information provided by Massachusetts General Hospital
First Received on September 13, 2005. Last Updated on June 18, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
ADHD
Bipolar Disorder
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
More general conditions related to this trial
Affective Disorders, Psychotic
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders
Mental Disorders Diagnosed in Childhood
Mood Disorders
Interventions listed in this trial
methylphenidate HCl (Concerta)
Additional drug interventions recognized in this trial
Methylphenidate
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Back to top of Main Content
